Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

587.37 -14.65 (-2.43%)
Official Closing Price Updated: 7:00 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,694,978
Open 600.97
Bid (Size) 545.19 (1)
Ask (Size) 605.31 (1)
Prev. Close 602.02
Today's Range 585.68 - 601.78
52wk Range 415.60 - 622.30
Shares Outstanding 393,418,899
Dividend Yield 0.24%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
Henrietta Lacks' family sues Novartis and Viatris for profiting from her HeLa cells without consent. The lawsuit seeks profits and aims to prevent further unauthorized use of the cells. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 15 Years
Via Benzinga

Performance

YTD
+7.94%
+7.94%
1 Month
+9.52%
+9.52%
3 Month
+2.53%
+2.53%
6 Month
+4.84%
+4.84%
1 Year
+6.45%
+6.45%

More News

Read More
Check Out What Whales Are Doing With TMO
Via Benzinga
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
Via InvestorPlace
3 Stocks With the Most Recent 52-Week Highs
Via InvestorPlace
Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
Navigating 5 Analyst Ratings For Thermo Fisher Scientific
Via Benzinga
Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today
Via Benzinga
3 Nanotechnology Stocks With Microscopic Risk
Via InvestorPlace
Apple To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Thermo Fisher Scientific (TMO) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Thermo Fisher Q2 Earnings: Marginal Revenue Dip, Completes Olink Acquisition, Lifts Annual Profit Outlook
Via Benzinga
Decoding Thermo Fisher Scientific's Options Activity: What's the Big Picture?
Via Benzinga
Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity
Via Benzinga
Looking At Thermo Fisher Scientific's Recent Unusual Options Activity
Via Benzinga
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move'
Via Benzinga
Thermo Fisher Scientific Reports Second Quarter 2024 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Nantotech Stocks to Bet On for Market-Crushing Returns
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stock Of The Day: How To Predict Thermo Fisher Scientific Trend Reversals
Via Benzinga
Thermo Fisher Scientific Declares Quarterly Dividend
From Thermo Fisher Scientific Inc.
Via Business Wire
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
Via Benzinga
Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
From Thermo Fisher Scientific Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.